LIFESCAN IP HOLDINGS LLC.

Company Snapshot

Founded: 1981
Entity Type: Private
Region: U.S.
Headquarter: U.S.
Key Geographics: North America
Corporate Address: 20 Valley Stream Parkway Malvern Pennsylvania 19355 U.S. Tel. +1-800-227-8862 www.lifescan.com

Company Overview

LifeScan Inc. manufactures diagnostics systems for the diabetes market, specifically blood glucose monitoring systems. LifeScan, previously under the ownership of Johnson & Johnson, became part of the J&J portfolio through acquisition in 1986. In June 2018, J&J sold LifeScan to Platinum Equity.

LifeScan manufactures the OneTouch Ultra and One Touch Verio product lines, which are designed for home use. In June 2018, Platinum Equity completed the acquisition of LifeScan from J&J for $2.1 billion.

LIFESCAN IP HOLDINGS LLC. In Reports

Global Diabetic Care Devices Market

BCC Research Report: Dive into diabetes care devices market report aims to provide a comprehensive study of the market Current and historical market revenues can be estimated based on the product type, end user and by...

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

BCC Research Market Analyst says global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028 at a CAGR of 9.8%.

Biosensors and Nanosensors: Global Markets and Technologies

BCC Research Market Report says global market for biosensors and nanosensors is expected to grow from $30.6 billion in 2023 to $43.5 billion by 2028, at a CAGR of 7.3%.

Company's Business Segments

  • Glucose Management and Diabetes Care  : The company provides a comprehensive portfolio of diabetes-based products and services for patients.

Applications/End User Industries

  • Healthcare